These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28235131)

  • 1. The effects of Share 35 on the cost of liver transplantation.
    Berumen J; Misel M; Vodkin I; Halldorson JB; Mekeel KL; Hemming A
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Impact of Liver Sharing and Organ Procurement Organizations' Experience With Share 35: Implications for National Broader Sharing.
    Fernandez H; Weber J; Barnes K; Wright L; Levy M
    Am J Transplant; 2016 Jan; 16(1):287-91. PubMed ID: 26372681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing variation in the costs of care among patients awaiting liver transplantation.
    Axelrod DA; Dzebisashvili N; Lentine K; Segev DL; Dickson R; Tuttle-Newhall E; Freeman R; Schnitzler M
    Am J Transplant; 2014 Jan; 14(1):70-8. PubMed ID: 24165015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy.
    Halazun KJ; Mathur AK; Rana AA; Massie AB; Mohan S; Patzer RE; Wedd JP; Samstein B; Subramanian RM; Campos BD; Knechtle SJ
    Am J Transplant; 2016 Jan; 16(1):137-42. PubMed ID: 26561981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK; Massie AB; Luo X; Wickliffe CE; Gentry SE; Cameron AM; Segev DL
    Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic implications of broader sharing of liver allografts.
    Axelrod DA; Gheorghian A; Schnitzler MA; Dzebisashvili N; Salvalaggio PR; Tuttle-Newhall J; Segev DL; Gentry S; Hohmann S; Merion RM; Lentine KL
    Am J Transplant; 2011 Apr; 11(4):798-807. PubMed ID: 21401867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
    Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA
    Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.
    Buchanan P; Dzebisashvili N; Lentine KL; Axelrod DA; Schnitzler MA; Salvalaggio PR
    Liver Transpl; 2009 Oct; 15(10):1270-7. PubMed ID: 19790155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    Brock GN; Washburn K; Marvin MR
    PLoS One; 2019; 14(10):e0223053. PubMed ID: 31581270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.
    Croome KP; Lee DD; Burns JM; Keaveny AP; Taner CB
    Liver Transpl; 2018 Apr; 24(4):488-496. PubMed ID: 29365357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same policy, different impact: Center-level effects of share 35 liver allocation.
    Murken DR; Peng AW; Aufhauser DD; Abt PL; Goldberg DS; Levine MH
    Liver Transpl; 2017 Jun; 23(6):741-750. PubMed ID: 28407441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.